A Real-World Study of JT001 for COVID-19

NCT06142201 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

7656

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: JT001

Sponsor

Shanghai Vinnerna Biosciences Co., Ltd.